Results

Total Results: 7,673 records

Showing results for "therapy".

  1. digital.ahrq.gov/sites/default/files/docs/quality-metrics-slides-042811.pdf
    January 01, 2011 - on individual patients not receiving essential medications UPQUAL Targets • CHD  Antiplatelet therapy … Physician Sees Patient Who Needs Testing or Treatment •Simple •No need to read •All pre-checked … • Physicians asked to review charts and either document exception or contact patient to initiate therapy … Board certification – Satisfaction measures – patients’ perception of the relative benefits of treatment … on quality and quantity of life balanced by the difficulty of undergoing the necessary treatment
  2. digital.ahrq.gov/sites/default/files/docs/publication/r18hs018648-atlas-final-report-2014.pdf
    January 01, 2014 - However, national and local data indicate that we are falling well short of treatment goals for these … Prior work done by our group demonstrated that PCPs were willing to start or change statin therapy … model of chronic disease medication management in which the decision to initiate or adjust medical therapy … linked to a sequence of subsequent clinical actions (e.g., monitoring for ADEs, assessing response to therapy … Laboratory testing options were to monitor treatment efficacy (LDL, HbA1c) and/or treatment safety
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/abTWXPvJyAMcqN9KcEt-vt
    September 06, 2016 - For each included study, one investigator extracted information about design, population, tests or treatments … The combina- tion therapy was found to be noninferior to isoniazid-only treat- ment. … .94 A later study by the same authors (described above) ran- domized 847 participants to the same 2 treatments … Limited usefulness of QuantiFERON-TB Gold In-Tube for monitoring anti-tuberculosis therapy. … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/wBcZfBcVp8N3-cyT3Peysv
    April 01, 2016 - Panel III treatment guidelines) (66). … The 11 pri- mary prevention studies are heterogeneous in terms of aspirin dose; duration of therapy; … conclude that the cardiovascular-related benefits (that is, nonfatal MI) occur during the first 5 years of therapy … AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic … Primary and secondary prevention of cardiovascular disease: Anti- thrombotic Therapy and Prevention of
  5. www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-nonpregnant-adults-and-adolescents-june-2016
    June 07, 2016 - Benefits of Early Detection and Treatment The USPSTF found convincing evidence that treatment with … headache, myalgia, and other symptoms), which may occur within the first 24 hours after any syphilis therapy … Sexually transmitted diseases treatment guidelines, 2015. … Epidemiologic treatment of contacts to infectious syphilis. … Therapy for incubating syphilis. Effectiveness of gonorrhea treatment.
  6. effectivehealthcare.ahrq.gov/products/prostate-cancer-radiation/research
  7. effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Off-label intranasal oxytocin for treatment of autism spectrum disorders No high-impact potential … Presently, behavioral therapies and pharmaceutical treatments are used to improve various symptoms … ES-3 Eligible Topic Not Deemed High Impact  Off-label intranasal oxytocin for treatment of autism
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
    May 01, 2013 - Are the same treatments known to be effective in general population similarly effective among women … depression and other outcomes without linking to screening; is there strong evidence for effective treatments … While treatments for postpartum depression are beyond the scope of this review, we agree that questions … completed and when they are completed, they are unlikely to lead to engagement with evidence-based treatments … cannot be effective. 4) We have revised the report to indicate that there are a range of potential treatments
  9. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/73643/psn-pdf
    August 01, 2022 - psnet.ahrq.gov//mailto:ljunge-m@bidmc.harvard.edu https://psnet.ahrq.gov//mailto:llipsitz@bidmc.harvard.edu treatment … medication, omission of a medication), monitoring errors, and missed opportunities for optimizing therapy
  10. Spotlight Case (ppt file)

    psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.127_slideshow.ppt
    May 01, 2006 - The orthopedist failed to elicit or to discover the history of the patient's previous diagnosis or treatment … It simply indicates that an undesirable clinical outcome resulted from some aspect of diagnosis or therapy
  11. psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.158_slideshow.ppt
    September 01, 2007 - Transitions in Care Multiple handoffs among health care providers Numerous changes to the patient’s therapeutic … Influence of hospitalization on drug therapy in the elderly. … Patient-physician communication at hospital discharge and patients' understanding of the postdischarge treatment
  12. psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.344_slideshow.ppt
    April 01, 2015 - 1-23. http://www.ncbi.nlm.nih.gov/pubmed/24804329 * Risk Management Pitfalls (2) Thrombolytic therapy
  13. psnet.ahrq.gov/web-mm/shake-well
    September 01, 2006 - Daily serum drug levels consistently fell below the therapeutic range, which led the physicians to gradually … In addition, 6% of doses are not administered; if a patient is not responding to therapy, an omission
  14. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49447/psn-pdf
    June 01, 2004 - The Commentary Many well-known factors contributing to drug therapy mishaps or misadventures were likely
  15. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49727/psn-pdf
    March 01, 2015 - reflect pathophysiological derangements at such variance with normal as to be life threatening if therapy
  16. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49814/psn-pdf
    December 01, 2017 - months previously, he had experienced a myocardial infarction and was started on dual antiplatelet therapy … Fortunately, the patient did not experience bleeding, a potential and sometimes devastating complication of therapeutic
  17. www.ahrq.gov/sites/default/files/wysiwyg/sops/events/webinar/03-sops-riverside-handoffs-webcast-hansford.pdf
    January 01, 2023 - Palliative Care, Hospice Care Mem ory Care, Ca re giver Support, Research, & Education Physical Therapy
  18. hcup-us.ahrq.gov/db/vars/disp/nisnote.jsp
    September 01, 2008 - For all years, the source disposition "Discharged to home under the care of a Home IV Drug Therapy provider
  19. psnet.ahrq.gov/web-mm/secured-not-always-safe
    October 01, 2015 - Following surgical drainage and continued antibiotic therapy, the patient improved clinically and was
  20. digital.ahrq.gov/sites/default/files/docs/page/reduction-in-hospital-acquired-complications-and-infections-quick-reference-guide.pdf
    January 01, 2010 - Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy